AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 80 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,404,400 | +3963.5% | 590,000 | +6696.5% | 0.16% | +7900.0% |
| Q2 2020 | $133,000 | +75.0% | 8,681 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $76,000 | +15.2% | 8,681 | 0.0% | 0.00% | +100.0% |
| Q4 2019 | $66,000 | -99.3% | 8,681 | -99.3% | 0.00% | -99.6% |
| Q1 2018 | $9,447,000 | -51.8% | 1,295,841 | -45.8% | 0.26% | -59.2% |
| Q4 2017 | $19,613,000 | -39.7% | 2,391,841 | -22.8% | 0.65% | +4.7% |
| Q3 2017 | $32,530,000 | +106.4% | 3,098,010 | +116.8% | 0.62% | -21.7% |
| Q2 2017 | $15,763,000 | +15.6% | 1,429,114 | +1.5% | 0.79% | +2.1% |
| Q1 2017 | $13,632,000 | -5.5% | 1,408,240 | +1.4% | 0.78% | -24.3% |
| Q4 2016 | $14,424,000 | – | 1,388,240 | – | 1.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 985,210 | $10,345,000 | 6.10% |
| Broadfin Capital, LLC | 3,568,122 | $37,465,000 | 5.54% |
| JW Asset Management, LLC | 444,439 | $4,667,000 | 3.42% |
| ARMISTICE CAPITAL, LLC | 1,688,000 | $17,724,000 | 2.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,655,494 | $38,383,000 | 1.73% |
| FALCON POINT CAPITAL, LLC | 661,490 | $6,284,000 | 0.91% |
| KNOTT DAVID M | 158,555 | $1,665,000 | 0.71% |
| Perceptive Advisors | 3,098,010 | $32,530,000 | 0.62% |
| Sio Capital Management, LLC | 91,413 | $960,000 | 0.50% |
| HEARTLAND ADVISORS INC | 700,000 | $7,350,000 | 0.48% |